テキサスにおける骨肉腫の臨床試験
テキサス内の拠点で、骨肉腫に関する10件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/29更新 · NCT04616560Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Children's Medical Center, Dallas
被験者募集中第1/2相
26歳以下 · 全性別 · 2026/09/03更新 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Medical Center, Dallas
被験者募集中第1/2相
30歳以下 · 全性別 · 2026/09/03更新 · NCT06541262Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- 他8件
被験者募集中第3相
50歳以下 · 全性別 · 2026/08/25更新 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
- Texas Children's Hospital, Houston
被験者募集中第1相
1歳〜24歳 · 全性別 · 2026/07/21更新 · NCT07211737Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1相
12歳〜50歳 · 全性別 · 2026/07/15更新 · NCT03093909Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
- M D Anderson Cancer Center, Houston
被験者募集中第2相
12歳以上 · 全性別 · 2026/04/17更新 · NCT05019703HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/01/22更新 · NCT04995003ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。